Instil Bio
TIL | NASDAQ
$5.75
-$0.33 (-5.43%)
At close: Nov 16, 2026, 4:00 PM ET
$5.75
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-5.43%
(1D)No price chart data available for 1D timeframe.
Rating
33.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #683/1021 (Top 67%)
Key Statistics
Market Data
Market Cap $39M
1D Range
5.31 6.08
52W Range
5.31 13.14
Valuation (TTM)
PE -1.29
PB 0.36
EV/EBITDA 0.91
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $7.00
Cash Flow
FCF Yield -60.5%
SBC Adj. FCF Yield -74.4%
SBC Impact -22.9%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 58.4% |
1.4%
FCF 3Y | 5Y 39.3% |
52.8%
Returns
ROA -15.3%
ROE -26.8%
ROIC -18.6%
Financial Health
Net Cash
$67.84M
Current Ratio 21.67
Interest Coverage -6.59
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in ...
Sector Healthcare
Industry Biotechnology
Employees 17
IPO Date Mar 19, 2021
Website instilbio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Hold
Price Target
$7.00
Upside
+21.74%
Buy (0)
Hold (3)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TIL